Loading...
XASXRMD
Market cap34bUSD
Dec 20, Last price  
36.81AUD
1D
-0.32%
1Q
4.04%
Jan 2017
329.02%
Name

Resmed Inc

Chart & Performance

D1W1MN
XASX:RMD chart
P/E
3.31
P/S
0.72
EPS
6.95
Div Yield, %
5.22%
Shrs. gr., 5y
0.42%
Rev. gr., 5y
12.44%
Revenues
4.69b
+10.95%
425,505,000606,996,000716,332,000835,397,000920,735,0001,092,357,0001,243,148,0001,368,515,0001,514,457,0001,554,973,0001,678,912,0001,838,713,0002,066,737,0002,340,196,0002,606,572,0002,957,013,0003,196,825,0003,578,127,0004,222,993,0004,685,297,000
Net income
1.02b
+13.75%
64,785,00088,211,00066,302,000110,303,000146,448,000190,085,000226,986,000254,850,000307,133,000345,273,000352,886,000352,408,000342,284,000315,588,000404,592,000621,674,000474,505,000779,437,000897,556,0001,020,951,000
CFO
1.40b
+102.11%
71,079,00099,028,00091,106,000137,836,000238,877,000188,213,000283,190,000383,159,000402,823,000391,268,000383,180,000547,932,000414,053,000505,026,000459,051,000802,255,000736,718,000351,147,000693,299,0001,401,260,000
Dividend
Aug 14, 20240.53 AUD/sh
Earnings
Jan 22, 2025

Profile

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
URL
https://www.resmed.com/
IPO date
Jun 01, 1995
Employees
10,140
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑062015‑06
Income
Revenues
4,685,297
10.95%
4,222,993
18.02%
3,578,127
11.93%
Cost of revenue
2,337,519
2,154,973
1,807,391
Unusual Expense (Income)
NOPBT
2,347,778
2,068,020
1,770,736
NOPBT Margin
50.11%
48.97%
49.49%
Operating Taxes
243,847
204,108
181,046
Tax Rate
10.39%
9.87%
10.22%
NOPAT
2,103,931
1,863,912
1,589,690
Net income
1,020,951
13.75%
897,556
15.15%
779,437
64.26%
Dividends
(282,320)
(258,276)
(245,341)
Dividend yield
1.00%
0.80%
0.80%
Proceeds from repurchase of equity
(96,917)
49,142
(5,022)
BB yield
0.34%
-0.15%
0.02%
Debt
Debt current
60,456
53,740
31,772
Long-term debt
1,005,479
1,686,859
1,028,087
Deferred revenue
137,343
119,186
95,455
Other long-term liabilities
42,257
105,349
54,856
Net debt
657,808
1,645,682
1,037,643
Cash flow
Cash from operating activities
1,401,260
693,299
351,147
CAPEX
(99,460)
(134,000)
(156,036)
Cash from investing activities
(269,784)
(1,159,845)
(229,918)
Cash from financing activities
(1,119,287)
422,874
(128,363)
FCF
2,201,290
1,321,467
954,317
Balance
Cash
238,361
227,891
273,710
Long term investments
169,766
(132,974)
(251,494)
Excess cash
173,862
Stockholders' equity
4,740,706
3,981,076
3,301,575
Invested Capital
5,768,994
5,956,265
4,383,719
ROIC
35.89%
36.05%
40.16%
ROCE
38.99%
34.20%
40.30%
EV
Common stock shares outstanding
147,550
147,455
147,043
Price
191.42
-12.39%
218.50
4.23%
209.63
-14.96%
Market cap
28,244,021
-12.34%
32,218,918
4.52%
30,824,624
-14.62%
EV
28,901,829
33,864,600
31,862,267
EBITDA
2,563,987
2,265,582
1,964,577
EV/EBITDA
11.27
14.95
16.22
Interest
45,708
47,379
22,312
Interest/NOPBT
1.95%
2.29%
1.26%